Schutt Aj
-
- Colorectal Cancer Treatments and Studies 9
- Cancer Treatment and Pharmacology 4
-
- Gastric Cancer Management and Outcomes 6
- Metastasis and carcinoma case studies 2
-
- Cancer Research and Treatments 4
-
- Cancer therapeutics and mechanisms 4
-
- Colorectal and Anal Carcinomas 3
-
- Beetle Biology and Toxicology Studies 2
- Cited by
- OncologyNeurologyGastroenterology
- Journals
- Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (32 papers)
- Partner nations
- United States
In The Last Decade
Schutt Aj
32 papers receiving 371 citations
Peers
Comparison fields: 5 of 67
- Oncology 227
- Neurology 83
- Gastroenterology 25
- Epidemiology 135
- Pathology and Forensic Medicine 50
Countries citing papers authored by Schutt Aj
This map shows the geographic impact of Schutt Aj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Schutt Aj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Schutt Aj more than expected).
Fields of papers citing papers by Schutt Aj
This network shows the impact of papers produced by Schutt Aj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Schutt Aj. The network helps show where Schutt Aj may publish in the future.
Co-authorship network
The 16 scholars most cited alongside Schutt Aj, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase II study of hycanthone in patients with advanced colorectal carcinoma. | 1983 | 4 |
| 2 | Phase II study of ftorafur in previously untreated and treated patients with advanced colorectal cancer. | 1983 | 3 |
| 3 | Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma. | 1982 | 1 |
| 4 | Phase II study of high-dose megestrol acetate in patients with advanced malignant melanoma. | 1982 | 7 |
| 5 | Phase II study of PALA in advanced large bowel carcinoma. | 1981 | 9 |
| 6 | Phase II trial of indicine N-oxide (INDI) in patients with advanced colorectal carcinoma. | 1981 | 7 |
| 7 | Phase II study of metronidazole therapy for advanced colorectal carcinoma. | 1978 | 4 |
| 8 | Phase II study of cytosine arabinoside in advanced large bowel cancer. | 1977 | 2 |
| 9 | Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer. | 1976 | 20 |
| 10 | Phase II study of cytembena (NSC-104801) in advanced colorectal carcinoma. | 1976 | 1 |
| 11 | Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinoma. | 1975 | 2 |
| 12 | Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinoma. | 1975 | 22 |
| 13 | Phase I study of chromomycin A (NSC-58514). | 1974 | 2 |
| 14 | Treatment of advanced squamous cell carcinoma of the gastrointestinal tract with bleomycin (NSC-125066). | 1974 | 19 |
| 15 | Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel. | 1974 | 42 |
| 16 | Effects of patient selection on results of phase II chemotherapy trials in gastrointestinal cancer. | 1974 | 19 |
| 17 | Effect of resection of the primary neoplasm on responsiveness to chemotherapy of patients with large bowel cancer. | 1972 | 2 |
| 18 | Phase II study of bleomycin (NSC-125066) therapy for large bowel cancer. | 1972 | 3 |
| 19 | Phase II study of 5-azacytidine (NSC-102816) in the treatment of advanced gastrointestinal cancer. | 1972 | 21 |
| 20 | A COMATOSE PATIENT. R'ESUM'E OF CASE. | 1964 | 1 |
About Schutt Aj
Schutt Aj is a scholar working on Oncology, Biotechnology and Pulmonary and Respiratory Medicine, having authored 33 papers that have together received 422 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (9 papers), Gastric Cancer Management and Outcomes (6 papers), Cancer Research and Treatments (4 papers), Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (4 papers), Colorectal and Anal Carcinomas (3 papers), Beetle Biology and Toxicology Studies (2 papers) and Metastasis and carcinoma case studies (2 papers). The work is most often cited by research in Oncology (227 citations), Neurology (83 citations) and Gastroenterology (25 citations). Schutt Aj has collaborated with scholars based in United States. Frequent co-authors include Moertel Cg, Robert G. Hahn, Ilstrup Dm, Carney Ja, van Heerden Ja, Martin Jk, O'Connell Mj, Adson Ma, J. Purvis and Stephen Frytak. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.